Katie Healy

736 total citations
18 papers, 391 citations indexed

About

Katie Healy is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Katie Healy has authored 18 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Katie Healy's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Katie Healy is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Katie Healy collaborates with scholars based in Sweden, United States and Germany. Katie Healy's co-authors include Margaret Chen, Haleh Davanian, Hassan Alkharaan, Rogier Gaiser, Roberto Valente, Carlos Fernández Moro, Luisa W. Hugerth, Marco Del Chiaro, Zeeshan Ateeb and Liyan Lu and has published in prestigious journals such as Blood, Gut and Scientific Reports.

In The Last Decade

Katie Healy

16 papers receiving 388 citations

Peers

Katie Healy
Katie Healy
Citations per year, relative to Katie Healy Katie Healy (= 1×) peers Barbara Holler

Countries citing papers authored by Katie Healy

Since Specialization
Citations

This map shows the geographic impact of Katie Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Healy more than expected).

Fields of papers citing papers by Katie Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Healy. The network helps show where Katie Healy may publish in the future.

Co-authorship network of co-authors of Katie Healy

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Healy. A scholar is included among the top collaborators of Katie Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Healy. Katie Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sobkowiak, Michał J., Katie Healy, Asif Halimi, et al.. (2025). Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids. Frontiers in Immunology. 16. 1553034–1553034.
2.
Andersson, Maria, Jinghua Wu, David Wullimann, et al.. (2023). Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia. Journal of Hematology. 12(4). 170–175. 3 indexed citations
3.
Healy, Katie, Giorgio Gabarrini, Michał J. Sobkowiak, et al.. (2023). Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV. Frontiers in Immunology. 13. 1079995–1079995. 4 indexed citations
4.
Silva, Daniela Nascimento, Michael Chrobok, Giulia Rovesti, et al.. (2022). Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products. Frontiers in Immunology. 13. 896242–896242. 10 indexed citations
5.
Healy, Katie, et al.. (2022). Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens. The Journal of Infectious Diseases. 227(10). 1214–1218. 3 indexed citations
6.
Gao, Yu, David Wullimann, Sandra Muschiol, et al.. (2022). Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination. Blood. 140(22). 2403–2407. 8 indexed citations
7.
Gibbs, Anna, Katie Healy, Christopher Sundling, et al.. (2022). Preserved Mucosal-Associated Invariant T Cells in the Cervical Mucosa of HIV-Infected Women with Dominant Expression of the TRAV1-2–TRAJ20 T Cell Receptor α-Chain. The Journal of Infectious Diseases. 226(8). 1428–1440. 6 indexed citations
8.
Healy, Katie, et al.. (2022). Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015–2018. Journal of Viral Hepatitis. 29(9). 835–839. 14 indexed citations
9.
Alkharaan, Hassan, Shaghayegh Bayati, Cecilia Hellström, et al.. (2021). Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. The Journal of Infectious Diseases. 224(3). 407–414. 34 indexed citations
10.
Bogdanović, Gordana, Marcus Buggert, Yu Gao, et al.. (2021). Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. Leukemia. 36(2). 476–481. 23 indexed citations
11.
Parrot, Tiphaine, Katie Healy, Caroline Boulouis, et al.. (2021). Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection. JCI Insight. 6(5). 35 indexed citations
12.
Akusjärvi, Sara Svensson, Anoop T. Ambikan, Shuba Krishnan, et al.. (2021). Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling. iScience. 25(1). 103607–103607. 10 indexed citations
13.
Healy, Katie, Andrea Pavesi, Tiphaine Parrot, et al.. (2021). Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions. JHEP Reports. 3(4). 100318–100318. 13 indexed citations
14.
Alkharaan, Hassan, Shaghayegh Bayati, Cecilia Hellström, et al.. (2021). Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. Zenodo (CERN European Organization for Nuclear Research).
15.
Healy, Katie, Anna Pasetto, Michał J. Sobkowiak, et al.. (2020). Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies. Cells. 9(6). 1471–1471. 4 indexed citations
16.
Gaiser, Rogier, Asif Halimi, Hassan Alkharaan, et al.. (2019). Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 68(12). 2186–2194. 172 indexed citations
17.
Davanian, Haleh, Rogier Gaiser, Luisa W. Hugerth, et al.. (2019). Mucosal-associated invariant T cells and oral microbiome in persistent apical periodontitis. International Journal of Oral Science. 11(2). 16–16. 25 indexed citations
18.
Gaiser, Rogier, Alberto Pessia, Zeeshan Ateeb, et al.. (2019). Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. Scientific Reports. 9(1). 10208–10208. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026